Russ Lehrman
rulehrman.bsky.social
Russ Lehrman
@rulehrman.bsky.social
Life scientist and entrepreneur alum #uwisconsin; alum @mcgill.ca; founder and CEO #BioSuperior; former co-founder #SnapDNA;
#NKTR #NXTR
Longtime biotech; protein_chemist; Dad;
You go! - #biosky #Firesign #Kitka #LGM
I was thrilled to present data that demonstrates that BioSuperior's novel drug delivery agent specifically targets #respiratory_therapeutics to lung tissue and improves lung function last week (January 14th) at #BiotechShowcase. #JPM25. #BioSuperior
January 25, 2025 at 9:50 PM
JPM week required hitching up my wagon at dawn and riding into SF for 3 days running. Managed to escape Covid despite all the face to face contact. Talking about innovations in respiratory medicine while watching the moon rise over the Salesforce tower? That's absolutely special!
January 25, 2025 at 2:09 AM
Personally, Biotech Showcase 2025, an important part of JPM week, was a blast. Many worthwhile conversations with people I value in the life science/biotech world - friends and new introductions. I'm looking forward to 2025!
January 25, 2025 at 1:57 AM
Reposted by Russ Lehrman
One of my frustrations with our work to understand the causes of #cancer #cachexia as part of Cancer Grand Challenges Team #CANCAN is the limitation of animal models that don't reflect the realities of the patient population. This development helps. #LCSM #lungcancer

www.biorxiv.org/content/10.1...
Concurrent PIK3CA mutant drives cachexia through inflammatory signaling in EGFR mutant lung cancer
PIK3CA mutation is frequently concurrent with known oncogenic drivers such as EGFR mutation in lung cancer, raising an interesting question about its real function. Cachexia is a systemic disease invo...
www.biorxiv.org
January 23, 2025 at 7:52 PM
I've gathered my social media belongings and moved to a new neighborhood. Those belongings include brooms and salt for my new community!
January 24, 2025 at 5:56 PM